REGALINS
Investo's verdict, shared with you
No fair value published
The derivation ran and was refused by our own plausibility checks. We publish no number rather than a plausible-looking one.
Why · 3 checks
Our valuation methods disagree
The earnings-based and book-based readings of this company differ by more than 2.5×. That spread is real information, but averaging it would manufacture a number no method actually produced.
Our own committee reads this differently
Our rules-based factor scorecard scores this company's Value factor the opposite way to our fair value. Both cannot be right, so neither is presented as settled.
A per-share input was repaired or refused
One of the per-share figures behind this valuation did not agree with the audited totals it should reconcile to, so it was recomputed from those totals or rejected outright.
What we would need
- Earnings and book value drawn from the same set of accounts, so the two legs can be reconciled.
- Agreement between the filing-derived valuation and the vendor ratios the committee scores.
- A per-share figure in the source data that reconciles to the reported totals.
Show what the engine computed
Method spread · 4.00× between the highest and lowest valuation leg.
Methods disagree · The valuation legs disagree by 4x (Blended P/E band ₦0.46 vs Blended P/B band ₦1.84 vs Justified P/B ₦0.92). No point estimate is defensible until the inputs are reconciled.
Committee disagrees · Committee scores Value NEGATIVE (cautious) but our base fair value implies +80.1% upside.
Figure corrected · independently sourced EPS ₦0.04 is 0.43x our filing-derived ₦0.09 — one of the two earnings bases is wrong; the P/E leg is unreliable until resolved
Input quality · independently sourced EPS ₦0.04 is 0.43x our filing-derived ₦0.09 — one of the two earnings bases is wrong; the P/E leg is unreliable until resolved
Source: NGX live market data · Investo intelligence. Educational only — not financial advice.